For: | Du FY, Zhou QF, Sun WJ, Chen GL. Targeting cancer stem cells in drug discovery: Current state and future perspectives. World J Stem Cells 2019; 11(7): 398-420 [PMID: 31396368 DOI: 10.4252/wjsc.v11.i7.398] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v11/i7/398.htm |
Number | Citing Articles |
1 |
Pawan Kumar Raghav, Zoya Mann. Cancer stem cells targets and combined therapies to prevent cancer recurrence. Life Sciences 2021; 277: 119465 doi: 10.1016/j.lfs.2021.119465
|
2 |
Mohini Singh, Ashish Dahal, Priscilla K. Brastianos. Preclinical Solid Tumor Models to Study Novel Therapeutics in Brain Metastases. Current Protocols 2021; 1(11) doi: 10.1002/cpz1.284
|
3 |
Thao Q. Pham, Kristin Robinson, Lin Xu, Maria N. Pavlova, Stephen X. Skapek, Eleanor Y. Chen. HDAC6 promotes growth, migration/invasion, and self-renewal of rhabdomyosarcoma. Oncogene 2021; 40(3): 578 doi: 10.1038/s41388-020-01550-2
|
4 |
Vivek Kumar, Mohit Vashishta, Lin Kong, Xiaodong Wu, Jiade J. Lu, Chandan Guha, B. S. Dwarakanath. The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.650772
|
5 |
Jiaying He, Shaomi Zhu, Xin Liang, Qinxiu Zhang, Xiaohong Luo, Chi Liu, Linjiang Song. LncRNA as a multifunctional regulator in cancer multi-drug resistance. Molecular Biology Reports 2021; 48(8): 1 doi: 10.1007/s11033-021-06603-7
|
6 |
Xin-Lei Wu, Shen-Guo Lin, Yi-Wen Mao, Jun-Xian Wu, Chen-Da Hu, Rui Lv, Hong-Dou Zeng, Ming-Hao Zhang, Li-Zi Lin, Shan-Shan Ouyang, Ya-Xin Zhao. Wnt/β-catenin signalling pathway in breast cancer cells and its effect on reversing tumour drug resistance by alkaloids extracted from traditional Chinese medicine. Expert Reviews in Molecular Medicine 2023; 25 doi: 10.1017/erm.2023.16
|
7 |
Priya Samanta, Arijit Bhowmik, Souradeep Biswas, Rupali Sarkar, Rituparna Ghosh, Shampa Pakhira, Mrinmoyee Mondal, Soummadeep Sen, Prosenjit Saha, Subhadip Hajra. Therapeutic Effectiveness of Anticancer Agents Targeting Different Signaling Molecules Involved in Asymmetric Division of Cancer Stem Cell. Stem Cell Reviews and Reports 2023; 19(5): 1283 doi: 10.1007/s12015-023-10523-3
|
8 |
Rhea Conchita Gonsalves, Ekta Tripathi, Prashanthi Karyala, Bilikere S. Dwarakanath, Vivek Kumar. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1 doi: 10.1007/978-981-16-1247-3_93-1
|
9 |
Raefa Abou Khouzam, Hassan Venkatesh Goutham, Rania Faouzi Zaarour, Ali N Chamseddine, Amirtharaj Francis, Stéphanie Buart, Stéphane Terry, Salem Chouaib. Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy. Seminars in Cancer Biology 2020; 65: 140 doi: 10.1016/j.semcancer.2020.01.003
|
10 |
Xu Gao, Qiong-Zhu Dong. Advance in metabolism and target therapy in breast cancer stem cells. World Journal of Stem Cells 2020; 12(11): 1295-1306 doi: 10.4252/wjsc.v12.i11.1295
|
11 |
Neha Shree Maurya, Ashutosh Mani. Navigating Molecular Pathways: An Update on Drugs in Colorectal
Cancer Treatment. Current Topics in Medicinal Chemistry 2023; 23(30): 2821 doi: 10.2174/1568026623666230614165548
|
12 |
Ginevra Passeri, Joshua Northcote-Smith, Kogularamanan Suntharalingam. Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex. Molecules 2023; 28(6): 2506 doi: 10.3390/molecules28062506
|
13 |
Yue Li, Jiaxin Fang, Kuldip Singh, Fabrizio Ortu, Kogularamanan Suntharalingam. An immunogenic anti-cancer stem cell bi-nuclear copper(ii)-flufenamic acid complex. Dalton Transactions 2024; 53(14): 6410 doi: 10.1039/D4DT00384E
|
14 |
Poornima Verma, Neha Shukla, Shivani Kumari, M.S. Ansari, Naveen Kumar Gautam, Girijesh Kumar Patel. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(3): 188887 doi: 10.1016/j.bbcan.2023.188887
|
15 |
Steven J. Tucker, Alina J. Zorn. The role of Popeye domain‐containing protein 1 (POPDC1) in the progression of the malignant phenotype. British Journal of Pharmacology 2022; 179(12): 2829 doi: 10.1111/bph.15403
|
16 |
Shigeo Saito, Chia-Chen Ku, Kenly Wuputra, Jia-Bin Pan, Chang-Shen Lin, Ying-Chu Lin, Deng-Chyang Wu, Kazunari K. Yokoyama. Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application. Journal of Personalized Medicine 2022; 12(5): 715 doi: 10.3390/jpm12050715
|
17 |
Vishalgiri G. Goswami, Bhumika D. Patel. Recent updates on Wnt signaling modulators: a patent review (2014-2020). Expert Opinion on Therapeutic Patents 2021; 31(11): 1009 doi: 10.1080/13543776.2021.1940138
|
18 |
Rhea Conchita Gonsalves, Ekta Tripathi, Prashanthi Karyala, Bilikere S. Dwarakanath, Vivek Kumar. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. 2022; : 1985 doi: 10.1007/978-981-16-5422-0_93
|
19 |
Kai Song, Maryam Farzaneh. Signaling pathways governing breast cancer stem cells behavior. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02321-w
|
20 |
Mahadi Hasan. Cancer Stem Cells: Basic Concept and Therapeutic Implications. 2023; : 271 doi: 10.1007/978-981-99-3185-9_15
|
21 |
Huiyun Liu, Daniel Heller-Trulli, Claire L. Moore. Targeting the mRNA endonuclease CPSF73 inhibits breast cancer cell migration, invasion, and self-renewal. iScience 2022; 25(8): 104804 doi: 10.1016/j.isci.2022.104804
|
22 |
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Federico Banchelli, Roberto D’Amico, Antonino Maiorana, Uliano Morandi, Massimo Dominici, Khawaja Husnain Haider. Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. Oncotarget 2021; 12(3): 230 doi: 10.18632/oncotarget.27870
|
23 |
Prashant S. Kharkar. Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives. Journal of Medicinal Chemistry 2020; 63(24): 15279 doi: 10.1021/acs.jmedchem.0c01336
|
24 |
R. Zou, Y. Wang, F. Ye, X. Zhang, M. Wang, S. Cui. Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome. Clinical and Translational Oncology 2021; 23(11): 2237 doi: 10.1007/s12094-021-02637-2
|
25 |
Xiaomei Wu, Zhumei Wei, Hui Feng, Hongli Chen, Jiaxiu Xie, Yupeng Huang, Mengyao Wang, Chanjuan Yao, Jianchun Huang. Targeting Effect of Betulinic Acid Liposome Modified by Hyaluronic Acid on Hepatoma Cells In Vitro. Journal of Pharmaceutical Sciences 2022; 111(11): 3047 doi: 10.1016/j.xphs.2022.06.015
|
26 |
Jiaxin Fang, Owamagbe N. Orobator, Chibuzor Olelewe, Ginevra Passeri, Kuldip Singh, Samuel G. Awuah, Kogularamanan Suntharalingam. A Breast Cancer Stem Active Cobalt(III)‐Cyclam Complex Containing Flufenamic Acid with Immunogenic Potential. Angewandte Chemie 2024; 136(6) doi: 10.1002/ange.202317940
|
27 |
Shingo Togano, Masakazu Yashiro, Go Masuda, Atsushi Sugimoto, Yuichiro Miki, Yurie Yamamoto, Tomohiro Sera, Shuhei Kushiyama, Sadaaki Nishimura, Kenji Kuroda, Tomohisa Okuno, Masaichi Ohira. Gastric cancer stem cells survive in stress environments via their autophagy system. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00155-3
|
28 |
Yejiao Ruan, Guangrong Lu, Yaojun Yu, Yue Luo, Hao Wu, Yating Shen, Zejun Gao, Yao Shen, Zhenzhai Cai, Liyi Li. PF-04449913 Inhibits Proliferation and Metastasis of Colorectal Cancer Cells by
Down-regulating MMP9 Expression through the ERK/p65 Pathway. Current Molecular Pharmacology 2023; 17 doi: 10.2174/1874467217666230915125622
|
29 |
Rachel K. Surowiec, Sarah F. Ferris, April Apfelbaum, Carlos Espinoza, Ranjit K. Mehta, Karamoja Monchamp, Veerin R. Sirihorachai, Karan Bedi, Mats Ljungman, Stefanie Galban. Transcriptomic Analysis of Diffuse Intrinsic Pontine Glioma (DIPG) Identifies a Targetable ALDH-Positive Subset of Highly Tumorigenic Cancer Stem-like Cells. Molecular Cancer Research 2021; 19(2): 223 doi: 10.1158/1541-7786.MCR-20-0464
|
30 |
Vigneshwari Easwar Kumar, Roshni Nambiar, Cristabelle De Souza, Audrey Nguyen, Jeremy Chien, Kit S. Lam. Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior. Cells 2022; 11(9): 1403 doi: 10.3390/cells11091403
|
31 |
Siyuan Qin, Jingwen Jiang, Yi Lu, Edouard C. Nice, Canhua Huang, Jian Zhang, Weifeng He. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00313-5
|
32 |
Yool Lee. Role of Vitamin C in Targeting Cancer Stem Cells and Cellular Plasticity. Cancers 2023; 15(23): 5657 doi: 10.3390/cancers15235657
|
33 |
Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad, Shifaa M. Abdin, Hany A. Omar. Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance. Critical Reviews in Oncology/Hematology 2020; 155: 103095 doi: 10.1016/j.critrevonc.2020.103095
|
34 |
Kuo-Shyang Jeng, I-Shyan Sheen, Chuen-Miin Leu, Ping-Hui Tseng, Chiung-Fang Chang. The Role of Smoothened in Cancer. International Journal of Molecular Sciences 2020; 21(18): 6863 doi: 10.3390/ijms21186863
|
35 |
Edoardo L. M. Gelardi, Giorgia Colombo, Francesca Picarazzi, Davide M. Ferraris, Andrea Mangione, Giovanni Petrarolo, Eleonora Aronica, Menico Rizzi, Mattia Mori, Concettina La Motta, Silvia Garavaglia. A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro. Cancers 2021; 13(2): 356 doi: 10.3390/cancers13020356
|
36 |
Jin-Yu Sun, Dengke Zhang, Songquan Wu, Min Xu, Xiao Zhou, Xiao-Jie Lu, Jiansong Ji. Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives. Biomarker Research 2020; 8(1) doi: 10.1186/s40364-020-00212-5
|
37 |
Jiaxi Yao, Yue Liu, Jitao Yang, Mengling Li, Simin Li, Bo Zhang, Rui Yang, Yuchong Zhang, Xiaoyu Cui, ChunQing Feng. Single-Cell Sequencing Reveals that DBI is the Key Gene and Potential Therapeutic Target in Quiescent Bladder Cancer Stem Cells. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.904536
|
38 |
Elisa Lozano, Paula Sanchon-Sanchez, Ana Morente-Carrasco, Luis Miguel Chinchilla-Tábora, José L. Mauriz, Paula Fernández-Palanca, Jose J. G. Marin, Rocio I. R. Macias. Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity. Cells 2023; 12(8): 1141 doi: 10.3390/cells12081141
|
39 |
Monica Sharma, Kevin Pruitt. Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks. International Journal of Molecular Sciences 2020; 21(21): 8018 doi: 10.3390/ijms21218018
|
40 |
Claudia Escudero-Lourdes, Ildemar Alvarado-Morales, Erik J. Tokar. Stem Cells as Target for Prostate cancer Therapy: Opportunities and Challenges. Stem Cell Reviews and Reports 2022; 18(8): 2833 doi: 10.1007/s12015-022-10437-6
|
41 |
Fatemeh Khojasteh Pour, Mona Keivan, Farhoodeh Ghaedrahmati, Najmieh Saadati, Farideh Moramezi, Roshan Nikbakht, Maryam Farzaneh. Endometrial Cancer Stem Cells Related Signaling Pathways. Current Cancer Therapy Reviews 2023; 19(4): 284 doi: 10.2174/1573394719666230306145642
|
42 |
Divya Ajmeera, Rajanna Ajumeera. Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance. Genes & Diseases 2024; 11(1): 148 doi: 10.1016/j.gendis.2022.12.013
|
43 |
Joyeeta Talukdar, Tryambak P. Srivastava, Om S. Sahoo, Abhibroto Karmakar, Avdhesh K. Rai, Anupam Sarma, Gayatri Gogoi, Mohammed S. Alqahtani, Mohamed Abbas, Ruby Dhar, Subhradip Karmakar. Cancer stem cells: Signaling pathways and therapeutic targeting. MedComm – Oncology 2023; 2(4) doi: 10.1002/mog2.62
|
44 |
Bruna Stefane Alves de Oliveira, Ana Carolina Correa de Assis, Natália Melo Souza, Luiz Fernando Romanholo Ferreira, Renato Nery Soriano, Muhammad Bilal, Hafiz M.N. Iqbal. Nanotherapeutic approach to tackle chemotherapeutic resistance of cancer stem cells. Life Sciences 2021; 279: 119667 doi: 10.1016/j.lfs.2021.119667
|
45 |
Karampal Singh, Joshua Northcote-Smith, Kuldip Singh, Kogularamanan Suntharalingam. Cancer stem cell activity of copper(ii)-terpyridine complexes with aryl sulfonamide groups. Dalton Transactions 2023; 52(28): 9694 doi: 10.1039/D3DT01294H
|
46 |
Juan M. Suárez-Rivero, Carmen J. Pastor-Maldonado, Suleva Povea-Cabello, Mónica Álvarez-Córdoba, Irene Villalón-García, Marta Talaverón-Rey, Alejandra Suárez-Carrillo, Manuel Munuera-Cabeza, Diana Reche-López, Paula Cilleros-Holgado, Rocío Piñero-Pérez, José A. Sánchez-Alcázar. Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?. Biomedicines 2022; 10(7): 1611 doi: 10.3390/biomedicines10071611
|
47 |
Babak Arjmand, Shayesteh Kokabi Hamidpour, Sepideh Alavi-Moghadam, Hanieh Yavari, Ainaz Shahbazbadr, Mostafa Rezaei Tavirani, Kambiz Gilany, Bagher Larijani. Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.768556
|
48 |
Liqun Yang, Pengfei Shi, Gaichao Zhao, Jie Xu, Wen Peng, Jiayi Zhang, Guanghui Zhang, Xiaowen Wang, Zhen Dong, Fei Chen, Hongjuan Cui. Targeting cancer stem cell pathways for cancer therapy. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-0110-5
|
49 |
Mohinder Pal Bansal. Redox Regulation and Therapeutic Approaches in Cancer. 2023; : 311 doi: 10.1007/978-981-99-7342-2_9
|
50 |
Joshua Northcote-Smith, Kogularamanan Suntharalingam. Targeting chemotherapy-resistant tumour sub-populations using inorganic chemistry: Anti-cancer stem cell metal complexes. Current Opinion in Chemical Biology 2023; 72: 102237 doi: 10.1016/j.cbpa.2022.102237
|
51 |
Shin Mukai. Possibilities and Limitations in Current Translational Stem Cell Research. Biochemistry 2023; 44 doi: 10.5772/intechopen.108963
|
52 |
Tao-Yan Lin, Jun-Shuang Jia, Wei-Ren Luo, Xiao-Lin Lin, Sheng-Jun Xiao, Jie Yang, Jia-Wei Xia, Chen Zhou, Zhi-Hao Zhou, Shu-Jun Lin, Qi-Wen Li, Zhi-Zhi Yang, Ye Lei, Wen-Qing Yang, Hong-Fen Shen, Shi-Hao Huang, Sheng-Chun Wang, Lin-Bei Chen, Yu-Lin Yang, Shu-Wen Xue, Yong-Long Li, Guan-Qi Dai, Ying Zhou, Ying-Chun Li, Fang Wei, Xiao-Xiang Rong, Xiao-Jun Luo, Bing-Xia Zhao, Wen-Hua Huang, Dong Xiao, Yan Sun. ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-02983-3
|
53 |
Vivek Kumar, Mohit Vashishta, B. S. Dwarakanath. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 2021; : 1 doi: 10.1007/978-981-15-4501-6_83-1
|
54 |
Plabon Kumar Das, Farhadul Islam, Robert A. Smith, Alfred K. Lam. Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.598957
|
55 |
Joshua Northcote‐Smith, Pooja Kaur, Kogularamanan Suntharalingam. A Cancer Stem Cell Potent Copper(II) Complex with a S, N, S‐Schiff base Ligand and Bathophenanthroline. European Journal of Inorganic Chemistry 2021; 2021(18): 1770 doi: 10.1002/ejic.202100125
|
56 |
Giuliana Catara, Antonino Colanzi, Daniela Spano. Combinatorial Strategies to Target Molecular and Signaling Pathways to Disarm Cancer Stem Cells. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.689131
|
57 |
Li-Fang Gu, Jia-Qi Chen, Qing-Yin Lin, Yan-Zhou Yang. Roles of mitochondrial unfolded protein response in mammalian stem cells. World Journal of Stem Cells 2021; 13(7): 737-752 doi: 10.4252/wjsc.v13.i7.737
|
58 |
Haroon Khan, Hamid Reza Mirzaei, Atefeh Amiri, Esra Kupeli Akkol, Syed Muhammad Ashhad Halimi, Hamed Mirzaei. Glyco-nanoparticles: New drug delivery systems in cancer therapy. Seminars in Cancer Biology 2021; 69: 24 doi: 10.1016/j.semcancer.2019.12.004
|
59 |
Jiaxin Fang, Owamagbe N. Orobator, Chibuzor Olelewe, Ginevra Passeri, Kuldip Singh, Samuel G. Awuah, Kogularamanan Suntharalingam. A Breast Cancer Stem Active Cobalt(III)‐Cyclam Complex Containing Flufenamic Acid with Immunogenic Potential. Angewandte Chemie International Edition 2024; 63(6) doi: 10.1002/anie.202317940
|
60 |
Ke Feng, Xiaojiang Li, Yuzhuo Bai, Dawei Zhang, Lin Tian. Mechanisms of cancer cell death induction by triptolide: A comprehensive overview. Heliyon 2024; 10(2): e24335 doi: 10.1016/j.heliyon.2024.e24335
|
61 |
Vivek Kumar, Mohit Vashishta, Bilikere S. Dwarakanath. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. 2022; : 1327 doi: 10.1007/978-981-15-9411-3_83
|
62 |
Alice Johnson, Xiao Feng, Kuldip Singh, Fabrizio Ortu, Kogularamanan Suntharalingam. The Anti-Breast Cancer Stem Cell Potency of Copper(I)-Non-Steroidal Anti-Inflammatory Drug Complexes. Molecules 2023; 28(17): 6401 doi: 10.3390/molecules28176401
|
63 |
Alice Johnson, Linda Iffland-Mühlhaus, Joshua Northcote-Smith, Kuldip Singh, Fabrizio Ortu, Ulf-Peter Apfel, Kogularamanan Suntharalingam. A bioinspired redox-modulating copper(ii)–macrocyclic complex bearing non-steroidal anti-inflammatory drugs with anti-cancer stem cell activity. Dalton Transactions 2022; 51(15): 5904 doi: 10.1039/D2DT00788F
|
64 |
|